20/20 Biolabs, Inc. Increase (Decrease) in Contract with Customer, Liability
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-14
- 20/20 Biolabs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $12.23K.
- 20/20 Biolabs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $31.04K.
- 20/20 Biolabs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was -$57.45K.
- 20/20 Biolabs, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was -$36.71K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|
| 2026-06-30 | $12.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $43.27K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $31.04K 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | -$63.77K POS AM · filed 2026-04-06 | ||
| 2025-06-30 | -$57.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$94.16K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$36.71K 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | $265.58K POS AM · filed 2026-04-06 |